Non paper distributed at SCCR 22 at 1pm on Friday, on disabilities

In a major breakthrough on the WIPO negotiations on copyright exceptions for persons with disabilities, at around 1pm today, a non-paper “resulting from informal discussions among Argentina, Brazil, Ecuador, the European Union and its Member States, Mexico, Paraguay and the United States of America” was distributed at the WIPO SCCR 22.

A copy of the document is available here:

/wp-content/uploads/text_distributed_friday_1pm.doc

Continue Reading

SCCR22: Intervention of Unión Latinoamericana de Ciegos (Latin American Union of the Blind)

On 16 June 2011, Pablo Lecuona delivered the following intervention on behalf of Intervention of Unión Latinoamericana de Ciegos at SCCR 22.

Gracias señor presidente.

Lo felicito ante todo por su elección al frente de este comité. hablo en Nombre de la Unión latinoamericana de Ciegos que reúne a las organizaciones de ciegos de los 19 países de América latina.

Continue Reading

1

Report from SCCR 22 discussions of WIPO treaty for persons who are blind or have other disabilities

WBU_IMG_0931.JPG
Members of the WBU delegation at WIPO SCCR 22

June 16, 10 am: There are good news and less good news to report from Geneva. While overall, things have moved in positive directions, with the US and the EU engaged in very constructive negotiations with Brazil and other treaty sponsors, there are still many frustrations. Continue Reading

Opening statement of Uruguay at WIPO’s 22nd Standing Committee on Copyright and Related Rights

Comité Permanente de Derechos de Autor y Conexos – SCCR 22 – OMPI – Ginebra
Intervención de la Delegación de Uruguay. Ginebra, 15 de junio de 2011.

Gracias Señor Presidente,

Señor Presidente, reciba de nuestra delegación nuestras mas sinceras felicitaciones por su designación como Presidente del Comité Permanente de Derechos de Autor y Conexos SCCR y cuente con nuestro apoyo para hacer una exitosa gestión al frente de este importante comité.

Señor Presidente:

Continue Reading

Uncategorized

Pharmaceutical global R&D was 7.9 percent of sales in 2010

Using industry assertions of R&D spending, pharmaceutical related R&D spending by the private sector was less than 8 percent of global sales in 2010.


sales_rnd_2010_0.png


These are the data:

2010 Global R&D by all private companies: – $67.4 billion
Source: Page 2 of the 2011 PhRMA industry profile
http://report.nih.gov/investigators_and_trainees/acd_bwf/pdf/Phrma_Industry_Profile_2011.pdf

2010 Global sales – $856 billion
Continue Reading

Uncategorized

KEI Intervention at UN HLM on HIV: De-Linking R&D costs from drug prices and the sustainability of treatment

un_hlm_panel_3_IMG_2446.JPGThese are the notes from my intervention today at the UN’s High Level Meeting on HIV/AIDS in New York. The persons making statements from the floor were asked to keep their comments to two minutes, so the actual intervention was somewhat shorter. Jamie

2011 High-Level Meeting on
the comprehensive review of the progress achieved in realizing
the Declaration of Commitment on HIV/AIDS and
Continue Reading

Uncategorized